to homepage ZF-pharma BV    The mission of ZF-screens BV is to develop products for pharmaceutical applications.
   One of our leading products, ZF-implant®, will be used as a tool for sustainable fish
   reproduction and is expected to be on the market soon.




to homepage NewCatch BV    The unique combination of expertise in both Fish Physiology and Molecular Cell Biology
   makes ZF-screens BV distinctive in this expanding market.
   
   
   



Pharmaceutical applications
ZF-pharma BV is a daughter company of ZF-screens that develops products for screening purposes based on zebrafish technologies.

Currently the main focus is on high throughput technologies for biomedical screens in the areas of infectious diseases and cancer research

Aquaculture applications
Daughter company NewCatch BV is developing ZF-implant® as a leading product.

This could in the near future enable fish farmers to control fish reproduction in aquaculture production, guaranteeing a normal development of the broodstock and high quality juveniles.


Latest News
22-3-2011
ZF-pharma starts collaboration with GSK for Tuberculosis screening

16-2-2011
Robot Injection system described in PloS ONE

17-02-2011
NewCatch BV signs agreement with Glasaal Volendam (in Dutch)


Last update 28 May 2010